Li et al. [54] demonstrated that EMT and MALAT1 overexpression were associated with TMZ in drug-resistant GBM cells, suggesting that MALAT1 was involved in EMT-induced chemotherapy resistance. The gene discussed is MALAT1; the disease is glioblastoma.